Beryl Capital Management’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Beryl Capital Management’s Portfolio MRNS Stock Details MRNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-4,227,460	Closed	-$2.26M	–	38
2024 Q4	$2.26M	Buy	+4,227,460	New	+$2.95M	0.51%	24

Beryl Capital Management's MRNS Position: Q1 2025 in Review

Beryl Capital Management sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q1 2025, closing a stake of 4,227,460 shares — an estimated $2.26M sold.

Beryl Capital Management first reported a position in MRNS in Q4 2024 and held it in 1 quarter. The position peaked at $2.26M in Q4 2024. 0 funds tracked by Wall St. Rank hold MRNS as of Q1 2025.

Beryl Capital Management reported no remaining Marinus Pharmaceuticals, Inc position as of Q1 2025 after selling out during the quarter.
Beryl Capital Management sold 4,227,460 Marinus Pharmaceuticals, Inc shares in Q1 2025, an estimated $2.26M.
Beryl Capital Management first reported a position in Marinus Pharmaceuticals, Inc in Q4 2024 and held it in 1 quarter.
Beryl Capital Management's Marinus Pharmaceuticals, Inc position peaked at $2.26M in Q4 2024.
0 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2025.

Based on Beryl Capital Management's 13F filing for Q1 2025, filed 15 May 2025.